3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Lead: new trials by email Literature Review of Lead trials Research Report on Lead
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®), Placebo, Docetaxel (Taxotere®) - Carcinoma, Non Small Cell Lung | Phase 3 | Completed | Sanofi | 913 | 2007-09-01 | 2025-09-10 |
| Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B Water 2mL PO 2 minutes prior to intra-muscular injection, skin-to-skin contact, Glucose 25% 2 mL PO 2 minutes prior to injection - Pain, Analgesia | Phase 3 | Completed | Federal University of São Paulo | 640 | 2006-03-01 | 2008-07-14 |
| Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk Micronutrient (Zinc and Iron) fortification, Pre and Probiotic fortification - Diarrhea, Pneumonia | Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 1200 | 2002-04-01 | 2005-11-18 |
Agnosia (1) · Carcinoma (1) · Diarrhea (1) · Lung Neoplasms (1) · Pain (1) · Pneumonia (1)
Federal University of São Paulo (1) · Johns Hopkins Bloomberg School of Public Health (1) · Sanofi (1)
India (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Czechia (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Greece (1)
Aurimery G Chermont (1) · Robert E Black, MD, MPH (1) · Ruth Guinsburg (1) · Sunil Sazawal, MD, MPH, PHD (1) · VenuGopal P Menon, PhD (1)
PMID 17132678, PMID 19948613, PMID 20730056, PMID 20730057, PMID 22965962, PMID 24428927